EN
HI
Colinz Laboratories Share Price
COLINZ
652.00 (-2.99%)
Last updated on 23 Oct, 2026 | 14:55 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 23 Oct, 2026, Colinz Laboratories stock price is ₹65. During the trading session, the stock has moved between an intraday low of ₹60.30 and an intraday high of ₹67.50. Over the last 52 weeks, Colinz Laboratories has traded between ₹36.11 and ₹87.91.
The stock has recorded a trading volume of 4,436 shares,. Its Average Traded Price (ATP) is ₹61.12, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 24 @ ₹65.00.
Colinz Laboratories has an upper circuit limit of ₹73.70 and a lower circuit limit of ₹60.30. The total value traded stands at ₹2.71 L, and the delivery percentage for the day is 76.06%.
The stock is currently traded with a market lot size of 1. Colinz Laboratories also offers a dividend yield of 0%.
Colinz Laboratories Share Price Chart
Colinz Laboratories Share Key Metrics
Volume
4436.00
Market Cap
16.88 CR
LTQ@LTP
24@65.00
ATP
61.12
Var Margin
29.97 %
Circuit Range
60.3-73.7
Delivery %
76.06 %
Value
2.71 L
ASM/GSM
No
Market Lot
1
Colinz Laboratories Resistance and Support
Pivot 67.23
Resistance
First Resistance
67.46
Second Resistance
67.93
Third Resistance
68.16
Support
First Support
66.76
Second Support
66.53
Third Support
66.06
Colinz Laboratories Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
50.6%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
49.4%
Others
0%
Total Promoters
MAR '26
66%
JUN '26
50.6%
SEP '26
50.6%
Colinz Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-30 | Quarterly Results |
| 2026-04-29 | Quarterly Results |
| 2026-01-24 | Quarterly Results |
| 2026-01-17 | Others |
| 2025-11-27 | Others |
| 2025-11-11 | Others |
| 2025-11-03 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-01-31 | Quarterly Results |
| 2024-10-30 | Quarterly Results |
| 2024-08-08 | Others |
Colinz Laboratories News
Colinz Laboratories Ltd - 531210 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Colinz Laboratories board to meet on 29 Oct 2026 for financial results. The primary agenda is to consider results for the quarter and half year ended Sep 2026.
Oct 19 2026 17:55:15
Colinz Laboratories Management
| Name | Position |
|---|---|
| Falguni Kumawat | Company Secretary & Compliance Officer |
| N K Menon | Whole Time Director |
Colinz Laboratories Similar Stocks
Beryl Drugs Ltd.
24.69
-0.20 (0.80%)
Sharma East India Hospitals & Medical Research Ltd
79.15
-8.15 (9.34%)
Norris Medicines Ltd.
15.00
0.00 (0.00%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
136.40
0.00 (0.00%)
Starsource Multitrade Ltd.
105.00
-3.30 (3.05%)
Broach Lifecare Hospital Ltd.
14.00
0.00 (0.00%)
Unjha Formulations Ltd.
28.97
-0.08 (0.28%)
Hindustan Bio Sciences Ltd.
6.90
-0.08 (1.15%)
Ortin Global Ltd.
12.60
-0.47 (3.60%)
Colinz Laboratories FAQs
The Buying Price of Colinz Laboratories share is 65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Colinz Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Colinz Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Colinz Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Colinz Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Colinz Laboratories’s valuation compare Sector P/E, P/B which are 38.79 & 3.22 with sector averages, along with growth rates and financial metrics.
The Market Cap of Colinz Laboratories is 16.88 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Colinz Laboratories share price is 87.91 & 36.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Colinz Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in COLINZ
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC